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ABSTRACT
Background: Symptomatic subxiphoid incisional hernias
present difficult surgical problems, especially in immuno-
suppressed cardiac transplant patients. Here, we describe
the laparoscopic repair of subxiphoid incisional hernias in
patients with a history of cardiac transplantation.
Methods: Four patients with subxiphoid hernias who had
previously undergone heart transplantation were identi-
fied from a prospective database. Each underwent a lapa-
roscopic repair with mesh implantation.
Results: Three patients had a previous open repair. The
mean age was 62.5 years, an average of 64.3 months after
transplantation. At the time of surgery, all patients were
immunosuppressed, and each had a subxiphoid, postster-
notomy incisional hernia. Gore dual mesh was used in 2
patients, while Parietex mesh was used in 2. Mean oper-
ative time was 122 minutes, and all were completed lapa-
roscopically. The mean length of stay was 6.5 days, and
the mean defect size was 286.25 cm
2. There was a signif-
icant correlation between hernia size and length of stay
(P0.037). Postoperatively, one patient (25%) developed
pulmonary edema, and 1 patient (25%) had a prolonged
ileus.
Conclusion: Symptomatic subxiphoid incisional hernias
are a challenging surgical problem in patients with a
history of sternotomy. Laparoscopic repair is safe and
effective in immunosuppressed patients who have previ-
ously undergone cardiac transplantation.
Key Words: Subxiphoid hernia, Cardiac transplant, Lapa-
roscopic repair, Immunosuppressed.
INTRODUCTION
Subxiphoid incisional hernia is an uncommon complica-
tion after median sternotomy. The precise incidence is not
known, because most hernias are small, asymptomatic,
and do not present to medical attention. Nonetheless, the
reported incidence is 1% to 4.2%.1–3 The hernia defect is
typically located in the caudad portion of the sternotomy,
where the incision enters the abdominal epigastrium, and
the defect is relatively protected from intestinal incarcer-
ation by the anterior surface of the liver.4 It is thought that
lateral traction forces on the abdominal wall predispose
this area to herniation.2 Predisposing factors include male
sex, obesity, postoperative wound infection, and left heart
failure.1 A retrospective study in a tertiary referral center
showed that 0.5% of all patients undergoing median ster-
notomy required operative hernia repair.5 There are no
data relating specifically to immunosuppressed patients
who had undergone cardiac transplantation.
As with all hernias, operative repair of subxiphoid inci-
sional hernias is indicated for symptoms or incarceration.
Due to the difficult anatomical location, results of conven-
tional hernia repair are poor. A recurrence rate of 43% to
80% has been reported with primary midline reapproxi-
mation of the fascia.5,6 Recurrence rates appear to be
lower with placement of nonresorbable mesh (0% to
32%).3,5,6 Proper placement of mesh requires dissection of
the retroxiphoid space to allow a subfascial position and
adequate overlap.4
The laparoscopic technique is especially attractive be-
cause it allows for excellent subfascial visualization of the
epigastrium and edges of the defect, avoidance of the
previous incision and minimal tissue trauma. As with all
laparoscopic ventral hernia repairs, proper fixation of the
mesh depends on the use of both transfascial sutures and
helical tacks.7 No tacks or sutures are placed in the ceph-
alad-most portion of the mesh during a subxiphoid inci-
sional hernia repair. This is thought to contribute to a
recurrence rate that is higher than laparoscopic repairs of
abdominal hernias in other sites. Recurrence rates with the
laparoscopic repair can be as high as 30%, but such results
are more likely related to a learning curve of the tech-
nique.5 Recurrences of 10% or less have been achieved
and should become the accepted norm.3,8,9
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SCIENTIFIC PAPERIn addition, this select population of patients is immuno-
suppressed further affecting wound healing. The use of
prednisone or sirolimus has been especially implicated in
postoperative wound problems in the transplant patient
population.10,11 Once a hernia develops in these patients,
it is possible that continued immunosuppression would
render them especially prone to recurrence, making the
laparoscopic approach especially attractive.
METHODS
All patients undergoing laparoscopic incisional hernia re-
pair were entered into a prospective longitudinal database
at the Yale-New Haven Hospital Minimally Invasive Sur-
gery Center. Between April 2003 and February 2007, four
patients who had previously undergone heart transplan-
tation were identified. All 4 patients presented electively
with symptomatic incisional hernias. No patients pre-
sented with incarceration. All patients presented to the
operating room at Yale-New Haven Hospital fully immu-
nosuppressed. All patients were given a single dose of
intravenous cephalosporin preoperatively. A cardiac an-
esthesiologist was involved in each case, and each patient
underwent a transesophageal echocardiogram intraoper-
atively. The peritoneal cavity was insufflated to 15mm Hg
with a Veress needle. Adhesiolysis and take down of the
falciform ligament was followed by measurement of the
hernia defect dimensions and introduction of the mesh. In
2 patients (50%), Parietex mesh (United States Surgical
Corporation, Norwalk, CT) was used, and Gore dual mesh
(W. L. Gore, Flagstaff, AZ) was used in the other 2 pa-
tients.
Mesh fixation was accomplished with the use of 6 to 8
transfascial nonabsorbable sutures in addition to spiral
tacks, ensuring at least 3-cm overlap beyond the edge of
the hernia defect circumferentially. The cephalad-most
portion of the mesh was not secured with either sutures or
tacks, but generous retroxiphoid overlap well beyond the
edge of the hernia was ensured. All patients were fitted
with an abdominal binder at the completion of the oper-
ation and recovered in the postanesthesia care unit. Im-
munosuppression was resumed on the first postoperative
day.
In the postoperative period, all patients were followed
primarily by the general surgical service in consultation
with the CHF/heart transplant medical service. Patients
were discharged home after bowel function was resumed,
they were tolerating a diet, and pain was well controlled
on oral medication.
Correlation between estimated hernia size and postoper-
ative length of stay was done using a paired t test. Signif-
icance was determined as P0.5.
RESULTS
Ninety-seven laparoscopic ventral/incisional hernia re-
pairs were performed between April 2003 and February
2007. Of these, 4 were repairs of poststernotomy subxi-
phoid epigastric hernias in patients who had previously
undergone cardiac transplantation. All 4 patients were
male (Table 1), ranging in age from 56 to 67 years old
(mean, 62.5). Each was taking one of the following im-
munosuppression regimens: mycophenolate mofetil and
cyclosporine, or mycophenolate mofetil, cyclosporine,
and prednisone, or mycophenolate mofetil, sirolimus, and
prednisone. The time since the heart transplant at the time
of hernia repair ranged from 13 months to 120 months
(mean, 64.3).
Three of the 4 patients (75%) presented with recurrent
incisional hernias that were previously repaired by a dif-
ferent surgeon, using the conventional open technique
with reapproximation of the fascia in the midline. All
patients were admitted electively for repair.
Abdominal insufflation to 15torr was accomplished with
the use of a Veress needle. Three 5-mm trocars and one
12-mm trocar were used in each case. The trocars were
positioned in the right upper quadrant, left upper quad-
rant, right midabdomen, and left midabdomen. The mean
defect size was 286.25cm2 (range, 144 to 600), and all
patients required a moderate adhesiolysis (Figures 1 and
2). No conversions to open were required. Postopera-
tively, 3 of the 4 patients were recovered in the postan-
esthesia care unit, while 1 patient was taken to the inten-
sive care unit for recovery during the first night for
monitoring. One patient had a minor postoperative com-
plication with delayed return of bowel function (5 days).
One patient had a major postoperative complication. Dur-
ing the first postoperative night, he developed significant
Table 1.
Patient Characteristics (N  4)
Male 4
Mean Age (yrs) 62.5 (range 56–67)
Mean Time Since Transplant (mos) 64.3 (range 12–120)
Previous Open Repair (%) 75
Mean Hospital Stay (d) 6.5 (range 2–15)
Mean Defect Size (cm
2) 286.25 (range 144–600)
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cause was identified. The patient responded to diuresis
and did not require intubation.
Average length of stay was 6.5 days (range, 2 to 15) and
correlated with hernia defect size (Figure 3). A paired t
test showed a significant correlation between hernia size
and postoperative length of stay (P0.037). Thirty-day
mortality was 0%. Hernia recurrence at 6 months was 0%.
DISCUSSION
Among incisional hernias, the poststernotomy subxiphoid
incisional hernia is uncommon. Conventional open pri-
mary repair of abdominal wall hernias has a high recur-
rence rate. Subfascial placement of mesh reduces this
significantly, and laparoscopy provides an effective, safe,
minimally invasive approach.12 The laparoscopic ap-
proach to repair of subxiphoid epigastric hernias has been
described in few reports in the literature with good suc-
cess.3,8 Here, we describe the successful laparoscopic re-
pair in a subset of these patients who had undergone
heart transplantation. Due to its anatomical position in the
epigastrium, this hernia poses a difficult surgical problem.
Adequate exposure of the hernia and placement of the
mesh usually requires dissection of the falciform ligament.
Securing the mesh in this region is especially difficult due
to the location proximity of the ribs, diaphragm, and
central tendon of the diaphragm. For this reason, we do
not secure the cephalad-most portion of the mesh that
apposes the central tendon of the diaphragm. Abdominal
pressure secures the mesh and adds strength to the repair,
and the left lobe of the liver and stomach make this region
relatively protected.
Heart transplantation and immunosuppression pose a
unique set of challenges in laparoscopic surgery. Despite
an increase in survival in heart transplant recipients, these
patients develop a host of comorbidities related to the
immunosuppressive treatment. Most of these patients over
time will develop hypertension, renal dysfunction, coro-
nary artery disease, and diabetes mellitus. Typically, re-
cipients of heart transplants exhibit some degree of dia-
stolic dysfunction as well, while the systolic function may
be normal. To safely manage these patients in the oper-
ating room, a thorough preoperative evaluation geared
mostly towards assessment of cardiovascular function is
mandatory. A preoperative transthoracic echocardiogram
or even a dobutamine stress echocardiogram should be
considered to evaluate the systolic and diastolic function
of the transplanted heart as well as cardiovascular reserve.
This information will allow the development of a prean-
esthetic plan that includes fluid management, use of ino-
Figure 1. Intraoperative view of subxiphoid incisional hernia
and postoperative adhesions.
Figure 2. Intraoperative view of subxiphoid hernia repair with
PTFE mesh.
Figure 3. Linear correlation between size of hernia defect and
postoperative length of stay.
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and appropriate adjustment of anesthetic drug doses. At
the same time, the surgeon and the anesthesiologist
should be prepared to operate at a lower than normal
abdominal insufflation pressure according to the cardio-
vascular reserve of the patient.
The hemodynamic changes incurred with laparoscopy
depend on the interaction of several factors including
pneumoperitoneum, intraabdominal pressures, carbon di-
oxide absorption, volume status, and patient position.
Typically, the compression of arterial and venous vascu-
lature produces an increase in systemic vascular resis-
tance, mean arterial pressure, filling pressures, and a de-
crease in preload and cardiac output. These changes are
well tolerated by healthy patients. Cardiac transplant re-
cipients, however, manifest an altered cardiac physiology.
The transplanted heart lacks autonomic innervation. As a
direct consequence, the normal tachycardic and inotropic
effect seen during abdominal insufflation is limited. Thus,
maintenance of adequate intravascular volume is of ex-
treme importance. However, as mentioned, most of these
patients exhibit diastolic dysfunction and are prone to
develop pulmonary edema when volume overloaded.
The preferred method for assessment of volume status
and myocardial function is the transesophageal echocar-
diogram, which can be performed intraoperatively. If this
option is not available then placement of a central line or
a pulmonary artery catheter should be considered. Due to
a wide variety of hemodynamic responses obtained with
abdominal insufflation, a radial artery catheter should be
considered in all heart transplant recipients undergoing
laparoscopic surgery.
Due to vagal denervation of the transplanted heart, the
resting heart rate will probably be 90 to 100 beats per
minute, and there will be a loss of bradycardic response to
stimuli, such as hypertension or carotid sinus massage.
Drugs that normally increase the heart rate by antimusca-
rinic effects (atropine) will have no effect on the trans-
planted heart. If an increase in heart rate is desired then
medications with direct -mimetic effect should be used
(isoproterenol or epinephrine).
Other considerations should be given to the heart trans-
plant recipient. Since these patients are immunosup-
pressed and prone to infection, timely administration of
preoperative antibiotic is mandatory. At the same time,
placement of central lines should be performed under
strict sterile conditions. If the patient is still on glucocor-
ticoids, an intraoperative stress dose of steroids should be
considered.
In the postoperative period, the patient should be placed
in a monitored setting (telemetry or intensive care unit).
Conditions that increase myocardial oxygen demand,
such as pain, shivering, and anemia, should be treated
promptly. Caution should be exhibited with volume ad-
ministration to prevent hypovolemia as well as the devel-
opment of pulmonary edema, as was the case with one of
our patients.
The outcome of this repair is excellent, and the result can
be life changing. One of our patients was a bilateral leg
amputee who could not exhibit sufficient mobility to be
fitted for prostheses, due to his very large incisional her-
nia. Following hernia repair, he was successfully fitted
with prostheses and is now ambulatory.
Due to the physiologic complexity of immunosuppressed
cardiac transplant patients, we believe it is important to
involve a dedicated cardiac anesthesiologist in these
cases. With this knowledge, the laparoscopic repair of a
poststernotomy incisional hernia in cardiac transplant pa-
tients can be performed safely and effectively. This repair
is technically challenging, yet it can be performed with
little morbidity and mortality.
We also found that the duration of the postoperative
length of stay was directly related to the size of the initial
hernia defect. This finding mirrored our results for all our
other laparoscopic incisional hernia repairs. A larger de-
fect likely reflects the amount of adhesiolysis that is re-
quired for repair and the potential extent of fluid shifts.
Both these factors can contribute to a prolonged postop-
erative course. Although we did not treat the wounds in
these immunosuppressed patients any differently than in
other patients, we saw no wound complications.
CONCLUSION
Symptomatic subxiphoid incisional hernias are a challeng-
ing surgical problem in patients with a history of sternot-
omy. Laparoscopic repair is feasible and safe in immuno-
suppressed patients who had previously undergone
cardiac transplant.
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